文献速递新发突发、热带与寄生虫病

循环寨卡与登革IgA-NS1标记出生后早期暴露,与先天性寨卡综合征相关小头症无显著关联

Circulating Zika and dengue IgA-NS1 marks early postnatal exposure without significant association with congenital Zika syndrome-related microcephaly.
PubMed 文献 · J Infect Dis · 2026-10-31

本研究在哥伦比亚登革热高度流行区分析164对母婴,评估寨卡病毒和登革病毒1-4型IgA-NS1应答。ZIKV和DENV1-4 IgA-NS1 ELISA的灵敏度/特异度分别为94%/97%和86%/85%,DENV暴露样本对ZIKV NS1有26%交叉反应。IgA-NS1无胎盘转移,ZIKV和DENV IgA-NS1水平在有或无CZS相关小头症的母婴间相当,但出生后随年龄增长而升高。结论:IgA-NS1是出生后正黄病毒暴露的标志物,但不参与对严重CZS结局的保护。

要点

  • IgA-NS1无胎盘转移,可作为婴儿出生后正黄病毒暴露的标志物。
  • 有或无CZS相关小头症的母婴间ZIKV和DENV IgA-NS1水平无差异。
  • DENV暴露样本对ZIKV NS1交叉反应率为26%。

核心结论

  • 循环IgA-NS1是婴儿出生后正黄病毒暴露的有前景标志物,但不似乎对严重CZS结局提供保护。
  • 针对小头症的保护性NS1介导免疫可能具有同种型依赖性。

研究设计与样本

  • 多中心研究,分析哥伦比亚2015-2016年寨卡流行期间164对确诊妊娠期ZIKV暴露的母婴。
  • 使用优化ELISA同时评估针对ZIKV和DENV1-4的循环IgA-NS1应答。
  • 通过儿科随访评估神经学结局,确定IgA-NS1与CZS相关小头症的关联。

主要发现

  • ZIKV IgA-NS1 ELISA灵敏度/特异度为94%/97%,DENV1-4为86%/85%。
  • DENV暴露样本对ZIKV NS1交叉反应率为26%。
  • 无胎盘转移证据,ZIKV和DENV IgA-NS1水平在有或无CZS相关小头症的母婴间相当。
  • 循环ZIKV和DENV IgA-NS1在出生后升高,年龄较大儿童中更高。

临床怎么用

  • IgA-NS1可作为评估婴儿出生后正黄病毒暴露的血清学标志物,因无胎盘转移干扰。
  • IgA-NS1水平不宜用于预测或评估CZS相关小头症的保护性免疫。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Elevated preexisting maternal IgG-NS1 to DENV, rather than to ZIKV, has been associated with a reduced risk of microcephaly in congenital Zika syndrome (CZS), suggesting a protective role. While serological analysis of IgG and IgM has physiological limitations in infants, IgA-NS1 represents a marker of host exposure to orthoflavivirus, as it is not transferred transplacentally and reflects early active immune responses. This study evaluated circulating IgA-NS1 responses to ZIKV and DENV in mothers and infants prenatally exposed to ZIKV in southern Colombia, a dengue hyperendemic region. METHODS: In this multicentric study, we analyzed 164 mother-infant pairs with confirmed gestational ZIKV exposure during the Colombia 2015-2016 epidemic. Using optimized ELISAs with well-characterized clinical samples, we simultaneously assessed circulating IgA-NS1 responses against ZIKV and DENV1-4. Neurological outcomes were evaluated through pediatric follow-up to determine associations between IgA-NS1 and CZS-related microcephaly. RESULTS: IgA-NS1 ELISAs for ZIKV and DENV1-4 achieved sensitivity/specificity of 94%/97% and 86%/85%, respectively. DENV-exposed samples showed 26% cross-reactivity against ZIKV NS1. There was no evidence of placental transfer, and IgA-NS1 levels for ZIKV and DENV were comparable between mothers and infants with or without CZS-related microcephaly. However, circulating ZIKV and DENV IgA-NS1 increased postnatally and were higher in older children. CONCLUSION: While circulating IgA-NS1 serves as a promising postnatal marker of orthoflavivirus exposure in infants due to its stability and lack of placental transfer, it does not appear to contribute to protection against severe CZS outcomes. These findings demonstrate that protective NS1-mediated immunity against microcephaly may be isotype-dependent.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Castro-Meneses J, Castro-Trujillo S, Mejía WR, et al. Circulating Zika and dengue IgA-NS1 marks early postnatal exposure without significant association with congenital Zika syndrome-related microcephaly. J Infect Dis. 2026. PMID: 42965304. doi:10.1093/infdis/jiag540

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。